Literature DB >> 11173943

Complications for radical cystectomy. Impact of the American Society of Anesthesiologists score.

B Malavaud1, C Vaessen, M Mouzin, P Rischmann, J Sarramon, C Schulman.   

Abstract

OBJECTIVES: To report the perioperative events after radical cystectomy and urinary diversion in bladder cancer in terms of major and minor complications and to seek statistical relationships with patient's characteristics and surgical procedures.
METHODS: One hundred and sixty-one radical cystectomies performed in the modern era in two academic hospitals were reviewed. Preoperative patients characteristics (age, sex, hemoglobin, total protein, weight and height) and perioperative data (operative time, type of urinary diversion, associated procedures, blood transfusion, seniority of the surgeon) were recorded. Perioperative morbidity was defined by any adverse event during hospital stay or within 30 days after surgery, those requesting an additional stay of more that 3 days in the intensive care unit or a reoperation being classified as major complications. Significant relationships were sought for classes by Student's t test for comparison of quantitative variables and Yate's corrected chi(2) test for categorical variables. Spearman's rank correlation test was used for comparison of quantitative variables.
RESULTS: Major complications were observed in 41 patients (25.5%) and resulted in 14 reoperations (8.7% reoperation rate). Most of them were diversion-related and were statistically related to the ASA score > or =3 (p<0.01, 5.7 odds ratio). Compared to sophisticated means of diversion, cutaneous diversion resulted in minimal operative time and hospital stay. No relationships between age, body mass index, biological parameters, type of diversion, associated procedure, surgeon's experience and postoperative complications could be evidenced. Uneventful recovery resulted in a 16.6 days mean hospital stay, minor complications induced a significant 3.8 days additional stay and major complications resulted in major lengthening of hospital stay (21.2 days mean additional stay).
CONCLUSION: ASA scores equal to or greater than 3 were associated with major complications and most specially those related to the type of urinary diversion. Therefore, we recommend special care in the selection of the type of urinary diversion and further preoperative evaluation inclusive of nutritional assessment.

Entities:  

Mesh:

Year:  2001        PMID: 11173943     DOI: 10.1159/000052416

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  18 in total

1.  Reduced length of stay in radical cystectomy patients with oral versus parenteral post-operative nutrition protocol.

Authors:  Peter Declercq; Gunter De Win; Frank Van der Aa; Elodie Beels; Beels Elodie; Lorenz Van der Linden; Hendrik Van Poppel; Ludo Willems; Willems Ludo; Isabel Spriet; Spriet Isabel
Journal:  Int J Clin Pharm       Date:  2015-02-10

Review 2.  [Imperative cystectomy in patients at risk. Ileal conduit or ureterocutaneostomy?].

Authors:  S Degener; A S Brandt; D A Lazica; F-C von Rundstedt; M J Mathers; S Roth
Journal:  Urologe A       Date:  2012-09       Impact factor: 0.639

3.  [Radical cystectomy and ileal neobladder reconstruction in elderly female patients over 70 years old: morbidity, functional and oncological long-term results].

Authors:  F Jentzmik; M Schrader; R de Petriconi; R Hefty; J Doetterl; A Eickhoff; A J Schrader
Journal:  Urologe A       Date:  2012-10       Impact factor: 0.639

4.  Comparison of readmission and short-term mortality rates between different types of urinary diversion in patients undergoing radical cystectomy.

Authors:  Bruno Nahar; Tulay Koru-Sengul; Feng Miao; Nachiketh Soodana Prakash; Vivek Venkatramani; Aliyah Gauri; David Alonzo; Mahmoud Alameddine; Sanjaya Swain; Sanoj Punnen; Chad Ritch; Dipen J Parekh; Mark L Gonzalgo
Journal:  World J Urol       Date:  2017-12-11       Impact factor: 4.226

5.  Factors affecting choice between ureterostomy, ileal conduit and continent reservoir after radical cystectomy: Japanese series.

Authors:  Toru Sugihara; Hideo Yasunaga; Hiromasa Horiguchi; Tetsuya Fujimura; Kiyohide Fushimi; Changhong Yu; Michael W Kattan; Yukio Homma
Journal:  Int J Clin Oncol       Date:  2014-01-07       Impact factor: 3.402

6.  Radical cystectomy in patients over 70 years of age: impact of comorbidity on perioperative morbidity and mortality.

Authors:  Vladimir Novotny; Stefan Zastrow; Rainer Koch; Manfred P Wirth
Journal:  World J Urol       Date:  2011-11-02       Impact factor: 4.226

7.  Hypofractionated radiation therapy for treatment of bladder carcinoma in patients aged 90 years and more: A new paradigm to be explored?

Authors:  Benoîte Méry; Alexander T Falk; Avi Assouline; Jane-Chloé Trone; Jean-Baptiste Guy; Romain Rivoirard; Pierre Auberdiac; Julien Langrand Escure; Coralie Moncharmont; Guillaume Moriceau; Hweej Almokhles; Guy de Laroche; Cécile Pacaut; Aline Guillot; Cyrus Chargari; Nicolas Magné
Journal:  Int Urol Nephrol       Date:  2015-05-17       Impact factor: 2.370

Review 8.  The health economics of bladder cancer: an updated review of the published literature.

Authors:  Christina Yeung; Tuan Dinh; Joseph Lee
Journal:  Pharmacoeconomics       Date:  2014-11       Impact factor: 4.981

9.  Radical cystectomy in the elderly patient: a contemporary comparison of perioperative complications in a single institution series.

Authors:  Derya Tilki; Dirk Zaak; Matthias Trottmann; Alexander Buchner; Yeliz Ekiz; Niklas Gerwens; Boris Schlenker; Alexander Karl; Sebastian Walther; Patrick J Bastian; Christian Gratzke; Stefan Tritschler; Ruth Knüchel-Clarke; Süleyman Ergün; Christian G Stief; Oliver Reich; Michael Seitz
Journal:  World J Urol       Date:  2009-10-22       Impact factor: 4.226

10.  Anatomical description of the umbilical arteries and impact of their ligation on pelvic and perineal vascular supply after cystectomy in women.

Authors:  E Chantalat; C Vaysse; M C Delchier; B Bordier; X Game; P Chaynes; E Cavaignac; M Roumiguié
Journal:  Surg Radiol Anat       Date:  2018-03-27       Impact factor: 1.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.